Amplifi Vascular

Amplifi Vascular is addressing a critical bottleneck in hemodialysis care: the high rate of arteriovenous fistula (AVF) ineligibility and failure due to small vein diameter. The company's Amplifi Vein Dilation System is a novel, pre-surgical device that uses a proprietary external blood pump to mechanically dilate veins, aiming to increase patient eligibility for the preferred AVF access, accelerate maturation, and improve long-term patency. As a pre-revenue, private company, its success hinges on clinical validation, regulatory clearance, and adoption by vascular surgeons, with the potential to significantly improve outcomes and reduce costs in the large end-stage renal disease market.

Proprietary wearable external blood pump system with catheters designed to apply controlled hemodynamic stress to dilate and prepare veins prior to arteriovenous fistula (AVF) creation surgery.

Competition includes existing surgical techniques for vein mapping and transposition, as well as potential off-label use of drug-coated balloons for venous dilation. The primary competitive advantage is the novel, dedicated mechanical approach to pre-surgical vein conditioning, which, if proven, could establish a new standard of care for marginal candidates.